TAM
RLAY icon

TFG Asset Management’s Relay Therapeutics RLAY Stock Holding History

TFG Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Buy
570,311
+388,768
+214% +$5.64M 1.68% 11
2026
Q1 		$1.81M Buy
+181,543
New +$1.62M 0.35% 30
2025
Q4 		– Sell
-223,123
Closed -$1.16M – 39
2025
Q3 		$1.16M Sell
223,123
-475,877
-68% -$1.81M 0.16% 34
2025
Q2 		$2.42M Buy
699,000
+80,000
+13% +$238K 0.39% 24
2025
Q1 		$1.62M Buy
+619,000
New +$2.43M 0.37% 23

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

TFG Asset Management's RLAY Position: Q2 2026 in Review

TFG Asset Management increased its Relay Therapeutics (RLAY) stake by 214% in Q2 2026, buying an estimated $5.64M and bringing the position to 570,311 shares worth $10.7M. The position accounts for 1.68% of the portfolio, ranked #11.

TFG Asset Management first reported a position in RLAY in Q1 2025 and has held it in 5 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • TFG Asset Management held 570,311 shares of Relay Therapeutics worth $10.7M as of Q2 2026.
  • TFG Asset Management bought 388,768 Relay Therapeutics shares in Q2 2026, an estimated $5.64M.
  • Relay Therapeutics made up 1.68% of TFG Asset Management's portfolio in Q2 2026, its #11 holding.
  • TFG Asset Management first reported a position in Relay Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on TFG Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.